Clinical Trial Update: COVID-19 Antibody Responses In Cystic Fibrosis

View source ↗

Summary

A clinical trial update indicating a study on COVID-19 antibody responses in cystic fibrosis patients is currently active but not recruiting, sponsored by Insel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Cystic Fibrosis | Status: ACTIVE_NOT_RECRUITING